These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26703218)

  • 1. Mechanisms for T cell tolerance induced with granulocyte colony-stimulating factor.
    Yang JZ; Zhang JQ; Sun LX
    Mol Immunol; 2016 Feb; 70():56-62. PubMed ID: 26703218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte colony-stimulating factor for the induction of T-cell tolerance.
    Rutella S
    Transplantation; 2007 Jul; 84(1 Suppl):S26-30. PubMed ID: 17632408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance.
    Rutella S; Zavala F; Danese S; Kared H; Leone G
    J Immunol; 2005 Dec; 175(11):7085-91. PubMed ID: 16301609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft monocytic myeloid-derived suppressor cell content predicts the risk of acute graft-versus-host disease after allogeneic transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood stem cells.
    Vendramin A; Gimondi S; Bermema A; Longoni P; Rizzitano S; Corradini P; Carniti C
    Biol Blood Marrow Transplant; 2014 Dec; 20(12):2049-55. PubMed ID: 25246295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of G-CSF in adaptive immunity.
    Franzke A
    Cytokine Growth Factor Rev; 2006 Aug; 17(4):235-44. PubMed ID: 16807060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of granulocyte colony-stimulating factor mobilization on the expression patterns, clonality and signal transduction of TRAV and TRBV repertoire.
    Xuan L; Wu X; Wu M; Zhang Y; Liu H; Fan Z; Sun J; Liu Q
    Immunobiology; 2012 Aug; 217(8):816-22. PubMed ID: 22658922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
    Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory CD4+CD25hi T cells conserve their function and phenotype after granulocyte colony-stimulating factor treatment in human hematopoietic stem cell transplantation.
    Noël G; Bruniquel D; DeGuibert S; Birebent B; Grosset JM; Bernard M; Dauriac C; Lamy-de-la-Chapelle T; Semana G; Brinster C
    Hum Immunol; 2008 Jun; 69(6):329-37. PubMed ID: 18571003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases.
    Franzke A; Piao W; Lauber J; Gatzlaff P; Könecke C; Hansen W; Schmitt-Thomsen A; Hertenstein B; Buer J; Ganser A
    Blood; 2003 Jul; 102(2):734-9. PubMed ID: 12676791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G-CSF mobilizes CD34+ regulatory monocytes that inhibit graft-versus-host disease.
    D'Aveni M; Rossignol J; Coman T; Sivakumaran S; Henderson S; Manzo T; Santos e Sousa P; Bruneau J; Fouquet G; Zavala F; Alegria-Prévot O; Garfa-Traoré M; Suarez F; Trebeden-Nègre H; Mohty M; Bennett CL; Chakraverty R; Hermine O; Rubio MT
    Sci Transl Med; 2015 Apr; 7(281):281ra42. PubMed ID: 25834108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell dose and differentiation.
    MacDonald KP; Rowe V; Filippich C; Johnson D; Morris ES; Clouston AD; Ferrara JL; Hill GR
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):373-85. PubMed ID: 15148491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of granulocyte colony stimulating factor for in vitro induction of regulatory T cells for cellular immune intervention in transplant medicine.
    Lammers SS; Ukena SN; Velaga S; Franzke A
    Exp Clin Transplant; 2013 Apr; 11(2):169-75. PubMed ID: 23432597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of heart allograft acceptability associated with recruitment of CD4+CD25+ T cells in peripheral blood by recipient treatment with granulocyte colony-stimulating factor.
    Liang HL; Yi DH; Zheng QJ; Du JF; Cao YX; Yu SQ; Zhu HL
    Transplant Proc; 2008 Jun; 40(5):1604-11. PubMed ID: 18589159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th2 polarization in target organs is involved in the alleviation of pathological damage mediated by transplanting granulocyte colony-stimulating factor-primed donor T cells.
    Zhou Y; Cao L; Guo H; Hong Y; Wang M; Wang K; Huang X; Chang Y
    Sci China Life Sci; 2021 Jul; 64(7):1087-1096. PubMed ID: 32880861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Third-party tolerogenic dendritic cells reduce allo-reactivity in vitro and ameliorate the severity of acute graft-versus-host disease in allo-bone marrow transplantation.
    Yang J; Li R; Ren Y; Yang Y; Xie R; Fan H
    Scand J Immunol; 2013 Dec; 78(6):486-96. PubMed ID: 24283771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
    Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte-macrophage colony-stimulating factor drives monocytes to CD14low CD83+ DCSIGN- interleukin-10-producing myeloid cells with differential effects on T-cell subsets.
    Ganguly D; Paul K; Bagchi J; Rakshit S; Mandal L; Bandyopadhyay G; Bandyopadhyay S
    Immunology; 2007 Aug; 121(4):499-507. PubMed ID: 17433076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte and granulocyte-macrophage colony-stimulating factors in allografts: uses, misuses, misconceptions, and future applications.
    Ringdén OT; Le Blanc K; Remberger M
    Exp Hematol; 2005 May; 33(5):505-12. PubMed ID: 15850828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
    Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L
    Bone Marrow Transplant; 2003 Jul; 32(1):49-56. PubMed ID: 12815478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-CSF induces a potentially tolerant gene and immunophenotype profile in T cells in vivo.
    Toh HC; Sun L; Soe Y; Wu Y; Phoon YP; Chia WK; Wu J; Wong KY; Tan P
    Clin Immunol; 2009 Jul; 132(1):83-92. PubMed ID: 19345152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.